1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil
Code | Size | Price |
---|
TAR-TNU0014-100mg | 100mg | £99.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-TNU0014-500mg | 500mg | £142.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil is a purine nucleoside analog with a broad spectrum of antitumor activity targeting inert lymphoid malignancies and inducing apoptosis.1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil is a purine nucleoside analog that exhibits a broad spectrum of antitumor activity targeting inert lymphoid malignancies. The anticancer mechanism of 1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil is dependent on the inhibition of DNA synthesis.
CAS:
69123-94-0
Formula:
C9H11FN2O5
Molecular Weight:
246.19
Pathway:
Apoptosis
Purity:
0.98
SMILES:
F[C@@H]1[C@@H](O[C@H](CO)[C@H]1O)N2C(=O)NC(=O)C=C2
Target:
Apoptosis
References
Robak T, et al. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.